Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urinary Bladder Neoplasms 1Renal Insufficiency 1Pancreatic Neoplasms 1Lung Neoplasms 1Hemangiosarcoma 1Gallbladder Neoplasms 1Disease 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1Carcinoma, Non-Small-Cell Lung 1Acute Kidney Injury 1

Interventions

Carboplatin 84Cisplatin 79Pemetrexed 72Docetaxel 62Drug Therapy 44Gemcitabine 43Erlotinib Hydrochloride 42Gefitinib 38Radiotherapy 36Paclitaxel 36pembrolizumab 31Bevacizumab 29icotinib 28osimertinib 27anlotinib 26Nivolumab 26camrelizumab 23Vinorelbine 23Radiosurgery 20aumolertinib 18atezolizumab 17sintilimab 16apatinib 16Endostatins 16endostar protein 15durvalumab 14Surgical Procedures, Operative 13Immunotherapy 13Immune Checkpoint Inhibitors 12Blood Specimen Collection 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Non-Small-Cell Lung × Urination × Clear all
NCT06341387 2024-04-02

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

European Institute of Oncology

Unknown
200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡